Reducing Risks in Autologous Cell Therapy Manufacture
The global Autologous Cell Therapy market is forecasted to increase at a rate of 17.7% from $9.29 billion in 2019 to $35.64 billion in 2027, according to reportsanddata.com. The major factors attributing to the growth of the autologous cell therapy business are the rising incidence of chronic conditions such as autoimmune diseases, cancer, blood disorders, and others.